Scynexis (SCYX) Current Leases (2019 - 2026)

Scynexis (SCYX) posted Current Leases of $504000.0 for Q1 2026, up 4.35% on a QoQ basis from $483000.0 in Q4 2025, and up 18.59% year-over-year from $425000.0 in Q1 2025.

Scynexis (SCYX) Current Leases (2019 - 2026) Analysis & Trends

Scynexis' Current Leases history runs 8 years deep, the most recent figure standing at $504000.0 for Q1 2026.

  • Quarterly Current Leases rose 18.59% year-over-year to $504000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $504000.0 (up 18.59% YoY) and the FY2025 annual result came in at $483000.0, up 18.67% from the prior year.
  • Current Leases was $504000.0 for Q1 2026 at Scynexis, up from $483000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $504000.0 in Q1 2026 and bottomed at $77000.0 in Q1 2022.
  • A 5-year average of $349470.6 and a median of $356000.0 in 2024 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2022 — Current Leases soared 313.85% — and 2026, when it climbed 18.59%.
  • Scynexis' Current Leases stood at $282000.0 in 2022, then gained by 20.57% to $340000.0 in 2023, then advanced by 19.71% to $407000.0 in 2024, then gained by 18.67% to $483000.0 in 2025, then increased by 4.35% to $504000.0 in 2026.
  • Business Quant data shows SCYX's Current Leases at $504000.0 in Q1 2026, $483000.0 in Q4 2025, and $463000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Scynexis 21.55 Mn -15.20 Mn - 504,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 504,000.00
Dec 31, 2025 483,000.00
Sep 30, 2025 463,000.00
Jun 30, 2025 444,000.00
Mar 31, 2025 425,000.00
Dec 31, 2024 407,000.00
Sep 30, 2024 389,000.00
Jun 30, 2024 372,000.00
Mar 31, 2024 356,000.00
Dec 31, 2023 340,000.00
Sep 30, 2023 325,000.00
Jun 30, 2023 310,000.00
Mar 31, 2023 296,000.00
Dec 31, 2022 282,000.00
Sep 30, 2022 269,000.00
Jun 30, 2022 199,000.00
Mar 31, 2022 77,000.00
Dec 31, 2021 70,000.00
Sep 30, 2021 65,000.00
Jun 30, 2021 60,000.00